Insider Buying: Tekla Healthcare Investors (HQH) Director Buys 1,100 Shares of Stock

Tekla Healthcare Investors (NYSE:HQH) Director Thomas M. Kent bought 1,100 shares of the stock in a transaction on Thursday, January 25th. The shares were acquired at an average cost of $24.19 per share, with a total value of $26,609.00. Following the acquisition, the director now directly owns 1,100 shares in the company, valued at approximately $26,609. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Tekla Healthcare Investors (NYSE:HQH) traded up $0.12 on Monday, reaching $24.74. 67,185 shares of the company’s stock were exchanged, compared to its average volume of 172,989. Tekla Healthcare Investors has a 12-month low of $21.75 and a 12-month high of $26.37. The firm has a market cap of $982.04, a price-to-earnings ratio of 8.40 and a beta of 1.73.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HQH. Tower Research Capital LLC TRC acquired a new stake in Tekla Healthcare Investors during the 2nd quarter worth $112,000. Acropolis Investment Management LLC acquired a new stake in Tekla Healthcare Investors during the 4th quarter worth $130,000. Laurel Wealth Advisors Inc. grew its holdings in Tekla Healthcare Investors by 0.6% during the 2nd quarter. Laurel Wealth Advisors Inc. now owns 9,581 shares of the financial services provider’s stock worth $240,000 after acquiring an additional 54 shares during the period. Advisor Group Inc. grew its holdings in Tekla Healthcare Investors by 0.3% during the 2nd quarter. Advisor Group Inc. now owns 10,518 shares of the financial services provider’s stock worth $264,000 after acquiring an additional 30 shares during the period. Finally, Moloney Securities Asset Management LLC acquired a new stake in Tekla Healthcare Investors during the 3rd quarter worth $367,000. 16.82% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This piece was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/29/insider-buying-tekla-healthcare-investors-hqh-director-buys-1100-shares-of-stock.html.

About Tekla Healthcare Investors

Tekla Healthcare Investors is a non-diversified closed-end healthcare fund. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. It seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets.

Receive News & Ratings for Tekla Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply